Home/Filings/4/0001127602-25-013478
4//SEC Filing

Frank Steven 4

Accession 0001127602-25-013478

CIK 0000882796other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 4:31 PM ET

Size

7.1 KB

Accession

0001127602-25-013478

Insider Transaction Report

Form 4
Period: 2025-05-02
Frank Steven
Director
Transactions
  • Award

    Automatic Stock Option Grant

    2025-05-02+4,0794,079 total
    Exercise: $8.93Exp: 2035-05-02Common Stock (4,079 underlying)
  • Award

    Common Stock

    2025-05-02+1,8661,866 total
Footnotes (3)
  • [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest in three equal annual installments beginning on the twelve-month anniversary of the date of grant.
  • [F2]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.
  • [F3]The option grant vests 1/36 per month over a 3-year period measured from the date of grant.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001583886

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 4:31 PM ET
Size
7.1 KB